Mucosal administration of substances to mammals
AssigneeBiovector Therapeutics, S.A.
InventorsDidier Betbeder, Alain Etienne, Ignacio de Miguel, Roger Kravtzoff, Michel Major
Life of this patent
Estimating the term…
Abstract
A novel method for the mucosal administration of a substance to a mammal is provided. The method comprises contacting a mucosal surface of the mammal with the substance in combination with a Biovector. The Biovector has a core that comprises a natural polymer, or a derivative or a hydrolysate of a natural polymer, or a mixture thereof. A preferred natural polymer is a polysaccharide or an oligosaccharide. The core is optionally coated with an amphiphilic compound, such as a lipid.
Claims48
A method for the mucosal administration of a substance to a mammal, the method comprising contacting a mucosal surface of the mammal with the substance in combination with a Biovector core, wherein the Biovector core comprises a natural polymer or a hydrolysate of a natural polymer, or a mixture thereof, and wherein the core is uncoated;
- or is partially or completely coated with no more than one layer, the layer comprising a lipid compound covalently bonded to the core, or an amphiphilic compound.
Dependencies are inferred from the claim text.